23Andme Holding Revenue vs. Current Valuation

ME Stock  USD 3.55  0.41  13.06%   
Considering the key profitability indicators obtained from 23Andme Holding's historical financial statements, 23Andme Holding Co may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess 23Andme Holding's ability to earn profits and add value for shareholders.
For 23Andme Holding profitability analysis, we use financial ratios and fundamental drivers that measure the ability of 23Andme Holding to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well 23Andme Holding Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between 23Andme Holding's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of 23Andme Holding Co over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

23Andme Holding Current Valuation vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining 23Andme Holding's current stock value. Our valuation model uses many indicators to compare 23Andme Holding value to that of its competitors to determine the firm's financial worth.
23Andme Holding Co is rated below average in revenue category among its peers. It also is rated below average in current valuation category among its peers reporting about  0.17  of Current Valuation per Revenue. The ratio of Revenue to Current Valuation for 23Andme Holding Co is roughly  5.81 . Comparative valuation analysis is a catch-all technique that is used if you cannot value 23Andme Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

23Andme Revenue vs. Competition

23Andme Holding Co is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 85.53 Billion. 23Andme Holding adds roughly 219.64 Million in revenue claiming only tiny portion of equities under Health Care industry.

23Andme Current Valuation vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

23Andme Holding

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
219.64 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

23Andme Holding

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
37.81 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

23Andme Current Valuation vs Competition

23Andme Holding Co is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 552.45 Billion. 23Andme Holding adds roughly 37.81 Million in current valuation claiming only tiny portion of equities under Health Care industry.

23Andme Holding Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in 23Andme Holding, profitability is also one of the essential criteria for including it into their portfolios because, without profit, 23Andme Holding will eventually generate negative long term returns. The profitability progress is the general direction of 23Andme Holding's change in net profit over the period of time. It can combine multiple indicators of 23Andme Holding, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
23andMe Holding Co. operates as a consumer genetics testing company. The company was founded in 2006 and is headquartered in South San Francisco, California. 23Andme Holding is traded on NASDAQ Exchange in the United States.

23Andme Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on 23Andme Holding. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of 23Andme Holding position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the 23Andme Holding's important profitability drivers and their relationship over time.

Use 23Andme Holding in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 23Andme Holding position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 23Andme Holding will appreciate offsetting losses from the drop in the long position's value.

23Andme Holding Pair Trading

23Andme Holding Co Pair Trading Analysis

The ability to find closely correlated positions to 23Andme Holding could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 23Andme Holding when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 23Andme Holding - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 23Andme Holding Co to buy it.
The correlation of 23Andme Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 23Andme Holding moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 23Andme Holding moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 23Andme Holding can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your 23Andme Holding position

In addition to having 23Andme Holding in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Services Thematic Idea Now

Business Services
Business Services Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Services theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Services Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
To fully project 23Andme Holding's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of 23Andme Holding at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include 23Andme Holding's income statement, its balance sheet, and the statement of cash flows.
Potential 23Andme Holding investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although 23Andme Holding investors may work on each financial statement separately, they are all related. The changes in 23Andme Holding's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on 23Andme Holding's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.